清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Clinical efficacy of low-dose plasma exchange combined with double plasma molecular absorption system/hemoperfusion in treatment of acute-on-chronic liver failure

作者
LU Jie
出处
期刊:DOAJ: Directory of Open Access Journals - DOAJ 被引量:1
链接
摘要

ObjectiveTo investigate the clinical efficacy of low-dose plasma exchange (PE) combined with artificial liver in the treatment of acute-on-chronic liver failure (ACLF) and its effect on mortality rate after stratification. MethodsA total of 272 ACLF patients who were admitted to Department of Infection and Hepatology, The First Affiliated Hospital of Kunming Medical University, from January 2018 to December 2020 were enrolled and divided into low-dose PE+double plasma molecular absorption system (DPMAS)/hemoperfusion (HP) group (n=190) and medical treatment group(n=82). Laboratory markers were collected before and after treatment, and clinical outcome was compared between the two groups; stratified analysis (early stage, early-middle stage, late stage or types A, B, C) was performed for the two groups according to Diagnostic and treatment guidelines for liver failure (2018 edition), and all patients were followed up to observe general status and death at 12 weeks (short-term) and 48 weeks (long-term) after discharge. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the paired samples t-test was used for comparison before and after treatment; the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups, and the Wilcoxon test was used for comparison before and after treatment; the chi-square test was used for comparison of categorical data between groups. ResultsBoth low-dose PE combined with DPMAS/HP and medical treatment alone could reduce the levels of alanine aminotransferase (ALT), aspartate aminotransferase, total bilirubin (TBil), and blood ammonia and increase the level of albumin (Alb), and both groups had significant changes in these indices after treatment (all P<0.05). Compared with medical treatment alone, low-dose PE combined with DPMAS/HP better reduced ALT, TBil, and blood ammonia and improved Alb, with significant changes in these indices after treatment (all P<0.05). Low-dose PE combined with DPMAS/HP could significantly reduce bile acid, international normalized ratio, neutrophil-lymphocyte ratio, and MELD score and increase platelet-to-white blood cell ratio (all P<0.05), while medical treatment alone could not improve the above indices (all P>0.05). Compared with medical treatment alone, low-dose PE combined with DPMAS/HP could reduce the short-term mortality rate of ACLF patients, especially the short-term mortality rate of ACLF patients with early-stage, early-middle-stage or type A ACLF, and there were significant differences between the two groups (all P<0.05). In the low-dose PE+DPMAS/HP group, the patients with early-stage ACLF had significantly lower short- and long-term mortality rates than those with late-stage ACLF, and the patients with type A ACLF had significantly lower short- and long-term mortality rates than those with type C ACLF (all P<0.05). ConclusionLow-dose PE combined with DPMAS/HP has good clinical efficacy and can effectively reduce the short-term mortality rate of ACLF, especially the short-term mortality rate of patients with early-stage, early-middle-stage, or type A ACLF.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
外向夜阑完成签到,获得积分10
刚刚
8秒前
大胆半双完成签到,获得积分10
11秒前
Wang发布了新的文献求助10
11秒前
17秒前
20秒前
风趣的飞阳完成签到,获得积分10
23秒前
cyj完成签到 ,获得积分10
33秒前
打打的应助被Wang采纳,获得10
46秒前
54秒前
1分钟前
勤劳的翩跹完成签到,获得积分10
1分钟前
文静的丹彤完成签到,获得积分10
1分钟前
TingtingGZ发布了新的文献求助10
1分钟前
蓝意完成签到,获得积分0
1分钟前
李健的应助被TingtingGZ采纳,获得10
1分钟前
英姑的应助被TingtingGZ采纳,获得10
1分钟前
科研通AI6.2的应助被TingtingGZ采纳,获得10
1分钟前
上官若男的应助被TingtingGZ采纳,获得10
1分钟前
Hello的应助被TingtingGZ采纳,获得10
1分钟前
科研通AI65的应助被TingtingGZ采纳,获得10
1分钟前
万能图书馆的应助被TingtingGZ采纳,获得10
1分钟前
molihuakai的应助被TingtingGZ采纳,获得10
1分钟前
李健的小迷弟的应助被TingtingGZ采纳,获得30
1分钟前
GingerF的应助被TingtingGZ采纳,获得200
1分钟前
1分钟前
快乐的稚晴完成签到,获得积分10
1分钟前
紫熊完成签到,获得积分10
1分钟前
热情菲鹰完成签到,获得积分10
1分钟前
Luoyan完成签到,获得积分10
1分钟前
1分钟前
优雅的傲柏完成签到,获得积分10
1分钟前
2分钟前
我想进步完成签到,获得积分10
2分钟前
坚强含烟完成签到,获得积分10
2分钟前
龙龙发布了新的文献求助10
2分钟前
2分钟前
2分钟前
随心所欲完成签到 ,获得积分10
2分钟前
Ava的应助被龙龙采纳,获得10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173194
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780476
捐赠科研通 7767279
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476682